Joseph L Alcorn Selected Research

mouse Comp protein

10/2009

An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph L Alcorn Research Topics

Disease

10	Pseudoachondroplasia 01/2017 - 04/2006
6	Inflammation (Inflammations) 01/2022 - 01/2011
5	Substance-Related Disorders (Drug Abuse) 10/2022 - 07/2012
4	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 04/2010 - 04/2006
3	Antisocial Personality Disorder (Antisocial Personality) 12/2015 - 07/2012
3	Respiratory Syncytial Virus Infections 10/2009 - 02/2005
2	Necrotizing Enterocolitis 01/2021 - 05/2015
2	Respiratory Hypersensitivity 11/2015 - 02/2005
2	Pneumonia (Pneumonitis) 11/2015 - 01/2011
2	Hypoxia (Hypoxemia) 05/2015 - 11/2013
2	Fibrosis (Cirrhosis) 02/2014 - 01/2011
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2011 - 02/2005
2	Lung Injury 01/2011 - 03/2010
1	Neoplasms (Cancer) 11/2021
1	Oral Ulcer (Mouth Ulcer) 01/2021
1	Mental Disorders (Mental Disorder) 12/2015
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 11/2013
1	Necrosis 02/2012
1	Lung Diseases (Lung Disease) 01/2011
1	Acute Lung Injury 03/2010
1	Body Weight (Weight, Body) 03/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2007
1	Atherosclerosis 03/2007
1	Premature Obstetric Labor (Premature Labor) 01/2007
1	Infections 12/2005
1	Adenocarcinoma 10/2004
1	Adenocarcinoma of Lung 04/2004

Drug/Important Bio-Agent (IBA)

9	Cartilage Oligomeric Matrix ProteinIBA 01/2017 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 01/2014 - 02/2005
6	Messenger RNA (mRNA)IBA 04/2010 - 04/2004
5	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 01/2022 - 12/2005
4	Surface-Active Agents (Surfactants)IBA 10/2011 - 04/2004
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2013 - 04/2004
3	Glycoproteins (Glycoprotein)IBA 04/2010 - 04/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2011
2	Pharmaceutical PreparationsIBA 12/2020 - 08/2016
2	4-aminospiroperidolIBA 12/2015 - 01/2013
2	CytokinesIBA 05/2015 - 10/2011
2	Extracellular Matrix ProteinsIBA 07/2014 - 04/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2014 - 03/2010
2	IgA receptor (protein B)IBA 02/2005 - 04/2004
1	Pregabalin (Lyrica)FDA Link 10/2022
1	LipopolysaccharidesIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 11/2021
1	Oleic Acid (Oleate)IBA 11/2021
1	Lactalbumin (alpha-Lactalbumin)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	Cocaine (Cocaine HCl)IBA 12/2020
1	Antisense OligonucleotidesIBA 01/2017
1	Therapeutic UsesIBA 12/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 12/2015
1	OzoneIBA 11/2015
1	Air Pollutants (Pollutants, Air)IBA 11/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2015
1	AntioxidantsIBA 07/2015
1	Caspase 3 (Caspase-3)IBA 11/2013
1	Tiagabine (Gabitril)FDA Link 07/2012
1	Apoptosis Inducing FactorIBA 02/2012
1	CaspasesIBA 02/2012
1	Adenosine DeaminaseIBA 01/2011
1	Adenosine (Adenocard)FDA LinkGeneric 01/2011
1	CollagenIBA 03/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2009
1	mouse Comp proteinIBA 10/2009
1	PPAR deltaIBA 03/2007
1	CCAAT-Enhancer-Binding Protein-betaIBA 03/2007
1	NF-kappa B (NF-kB)IBA 01/2007
1	Collagen Type IXIBA 01/2007
1	Matrilin ProteinsIBA 01/2007
1	Progesterone FDA LinkGeneric 01/2007
1	Complement System Proteins (Complement)IBA 04/2006
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 12/2005
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 12/2005
1	sinapultideIBA 02/2005
1	NitritesIBA 02/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2005
1	InterferonsIBA 02/2005
1	1,2-Dipalmitoylphosphatidylcholine (Dipalmitoylphosphatidylcholine)IBA 02/2005
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2005
1	lucinactantIBA 02/2005
1	Peptides (Polypeptides)IBA 02/2005
1	Betamethasone (Celestone)FDA Link 04/2004

Therapy/Procedure

3	Therapeutics 01/2017 - 01/2014
1	Oral Administration 05/2015
1	Transplantation 03/2010